This work was partly supported by funding from the Japan Science and Technology Agency (JST) for “Development of system and technology for advanced measurement and analysis (SENTAN)” and for “Innovation COE Program for Future Drug Discovery and Medical Care”. We are grateful to Dr. Y. Shinohara, Dr. Y. Miura, and Dr. H. Nakagawa for valuable suggestions and discussions on mouse serum N-glycan profiling.
Reverse Glycoblotting Allows Rapid-Enrichment Glycoproteomics of Biopharmaceuticals and Disease-Related Biomarkers†
Article first published online: 17 OCT 2007
Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 119, Issue 46, pages 8964–8969, November 26, 2007
How to Cite
Kurogochi, M., Amano, M., Fumoto, M., Takimoto, A., Kondo, H. and Nishimura, S.-I. (2007), Reverse Glycoblotting Allows Rapid-Enrichment Glycoproteomics of Biopharmaceuticals and Disease-Related Biomarkers. Angew. Chem., 119: 8964–8969. doi: 10.1002/ange.200702919
- Issue published online: 16 NOV 2007
- Article first published online: 17 OCT 2007
- Manuscript Received: 1 JUL 2007
- Japan Science and Technology Agency (JST)
Supporting information for this article is available on the WWW under http://www.wiley-vch.de/contents/jc_2001/2007/z702919_s.pdf or from the author.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.